NOX 1.52% 6.7¢ noxopharm limited

Ann: Noxopharm March 2020 Quarterly Report & Appendix 4C, page-3

  1. 875 Posts.
    lightbulb Created with Sketch. 239
    I suppose the pending announcement on the FDA approval for trialling Veyonda against Covid-19 will be used as a catalyst to bolster the SP in the coming weeks.

    From a TA point of view I see this possibly having a nudge between 29c to 35c and may get there with that news within the specified 4 weeks. My mobile chart is a little crude but you can see an inverse H&S pattern there.

    https://hotcopper.com.au/data/attachments/2128/2128270-d3cf871b227a6fe0eaf9c4b0a2a56e77.jpg


 
watchlist Created with Sketch. Add NOX (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.